Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 19, 2001
Thalidomide is distributed into human semen after oral dosingS K Teo, J L Harden, A B Burke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 24, 1999
Changes in AIDS-defining illnesses in a London Clinic, 1987-1998A Mocroft, C A Sabin, M Youle, et al.
International Journal of STD & AIDS|May 17, 2008
Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002)E J Beck, S Mandalia, M Youle, et al.
Annals of Internal Medicine|February 15, 1997
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trialJ P Lalezari, R J Stagg, B D Kuppermann, et al.
AIDS (London, England)|February 24, 2001
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centreA Mocroft, M Youle, A Moore, et al.
HIV Medicine|December 12, 2001
A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infectionD E Smith, J Bell, M Johnson, et al.
The Journal of Cell Biology|September 13, 2017
Mitochondrial fission facilitates the selective mitophagy of protein aggregatesJonathon L Burman, Sarah Pickles, Chunxin Wang, et al.
Sexually Transmitted Infections|January 30, 1999
Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trialE T Katabira, N K Sewankambo, R D Mugerwa, et al.
The Journal of Infectious Diseases|June 9, 2001
The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected personsA I Veldkamp, M Harris, J S Montaner, et al.
The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.
Pageof 8